SCHEMBL8510463

SCHEMBL8510463

O=C(O)Cc1ccc(O)c(I)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.68
HSD17B10 Q99714 4/20 0.68
GAA P10253 4/20 0.68
LMNA P02545 4/20 0.68
TSHR P16473 4/20 0.68
POLB P06746 3/20 0.68
HIF1A Q16665 3/20 0.68
KDM4E B2RXH2 3/20 0.68
MAPT P10636 3/20 0.68
NFKB1 P19838 2/20 0.68
TDP1 Q9NUW8 2/20 0.68
RGS12 O14924 1/20 0.68
APEX1 P27695 1/20 0.68
THPO P40225 1/20 0.68
BLM P54132 1/20 0.68
GNAI1 P63096 1/20 0.68
PMP22 Q01453 1/20 0.68
THRA P10827 4/20 0.64
THRB P10828 4/20 0.64
PCNA P12004 4/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30716576 1.00 HPGD (0.68) HPGDHSD17B10GAALMNATSHR
SCHEMBL26617181 0.86 PCNA (0.49) HPGDHSD17B10GAALMNATSHR
SCHEMBL11052875 0.85 PCNA (0.49) HPGDHSD17B10GAALMNATSHR
SCHEMBL16114045 0.84 HPGD (0.68) HPGDHSD17B10GAALMNATSHR
SCHEMBL1599014 0.83 THRB (0.71) HPGDHSD17B10GAALMNATSHR
SCHEMBL19420576 0.82 THRB (0.46) HPGDHSD17B10GAALMNATSHR
3,4-Dihydroxyphenylacetic Acid SCHEMBL29382155 0.81 GAA (1.00) HPGDHSD17B10GAALMNATSHR
3,4-Dihydroxyphenylacetic Acid SCHEMBL36348 0.81 GAA (1.00) HPGDHSD17B10GAALMNATSHR
SCHEMBL3269085 0.81 PCNA (0.66) HPGDHSD17B10GAALMNATSHR
SCHEMBL30492043 0.81 PCNA (0.66) HPGDHSD17B10GAALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815872-A2 Compounds for targeting IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1998-01-07 EP claimed
EP-0679094-A1 COMPOUNDS FOR TARGETING IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1995-11-02 EP claimed
WO-1994015644-A1 COMPOUNDS FOR TARGETING IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1994-07-21 WO claimed
US-20160032047-A1 Peg-based adhesive phenylic derivatives and methods of synthesis and use DSM IP ASSETS B.V. (NL) 2016-02-04 US disclosed
EP-2968667-A1 PEG-BASED ADHESIVE PHENYLIC DERIVATIVES AND METHODS OF SYNTHESIS AND USE DSM IP Assets B.V. (NL) 2016-01-20 EP disclosed
WO-2014158288-A1 PEG-BASED ADHESIVE PHENYLIC DERIVATIVES AND METHODS OF SYNTHESIS AND USE DSM IP ASSETS B.V. (NL) 2014-10-02 WO disclosed
US-5973116-A CYTOTOXIC COMBINATIONS OF COMPOUNDS, THAT HAVE A HIGH AVIDITY FOR, AND CAN BE TARGETED TO, SELECTED CELLS. TARGETING OF COMPOUNDS WHICH ARE DIRECTLY, OR INDIRECTLY, CYTOTOXIC HAS BEEN PROPOSED AS A WAY TO COMBAT DISEASES SUCH AS CANCER. IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1999-10-26 US disclosed
EP-0815872-A2 Compounds for targeting IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1998-01-07 EP disclosed
EP-0679094-A1 COMPOUNDS FOR TARGETING IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1995-11-02 EP disclosed
WO-1994015644-A1 COMPOUNDS FOR TARGETING IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) 1994-07-21 WO disclosed